ACUTE GOUT FLARE
Clinical trials for ACUTE GOUT FLARE explained in plain language.
Never miss a new study
Get alerted when new ACUTE GOUT FLARE trials appear
Sign up with your email to follow new studies for ACUTE GOUT FLARE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gout pill aims to ease flare pain in days
Symptom relief Recruiting nowThis study tests whether a tablet called dapansutrile can safely reduce joint pain during an acute gout flare. About 300 adults with gout will receive either the study drug or a placebo. The main goal is to measure pain relief 72 hours after the first dose.
Matched conditions: ACUTE GOUT FLARE
Phase: PHASE2, PHASE3 • Sponsor: Olatec Therapeutics LLC • Aim: Symptom relief
Last updated May 17, 2026 11:48 UTC
-
New antibody injection aims to ease gout flare pain
Symptom relief Recruiting nowThis early-stage study tests a single dose of a new antibody injection in 64 people to see if it is safe and how the body processes it. Part A includes healthy volunteers, and Part B includes people currently having an acute gout flare. The goal is to gather safety and drug-level…
Matched conditions: ACUTE GOUT FLARE
Phase: PHASE1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
New gout drug aims to beat standard treatment in pain showdown
Symptom relief Recruiting nowThis study tests a new medicine called ABP-745 to see if it reduces pain and swelling from an acute gout flare better than the standard drug colchicine or a placebo. About 380 adults aged 18 to 70 who have had at least two gout flares in the past year will take part. The main goa…
Matched conditions: ACUTE GOUT FLARE
Phase: PHASE2 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC